Game-Changer? Wegovy Cuts Heavy Drinking in Alcohol Addiction Trial

(MedPage Today) -- People with obesity and alcohol use disorder had fewer heavy drinking days while on semaglutide (Wegovy), a Danish randomized trial showed. Alongside cognitive behavioral therapy, adults receiving a 2.4-mg weekly dose of the...
Source
MedPage Today
Opens original article in a new tab



